BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35256245)

  • 1. Time interval between diagnostic excision-biopsy of a primary melanoma and sentinel node biopsy: effects on the sentinel node positivity rate and survival outcomes.
    El Sharouni MA; Scolyer RA; van Gils CH; Ch'ng S; Nieweg OE; Pennington TE; Saw RPM; Shannon K; Spillane A; Stretch J; Witkamp AJ; Sigurdsson V; Thompson JF; van Diest PJ; Lo SN
    Eur J Cancer; 2022 May; 167():123-132. PubMed ID: 35256245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the time interval between melanoma diagnosis and sentinel node biopsy on the size of metastatic tumour deposits in node-positive patients.
    El Sharouni MA; Scolyer RA; van Gils CH; Ch'ng S; Nieweg OE; Pennington TE; Saw RP; Shannon K; Spillane A; Stretch J; Witkamp AJ; Sigurdsson V; Thompson JF; van Diest PJ; Lo SN
    Eur J Cancer; 2022 May; 167():133-141. PubMed ID: 35216870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of time interval between primary melanoma excision and sentinel node biopsy on positivity rate and survival.
    Oude Ophuis CM; van Akkooi AC; Rutkowski P; Voit CA; Stepniak J; Erler NS; Eggermont AM; Wouters MW; Grünhagen DJ; Verhoef CK
    Eur J Cancer; 2016 Nov; 67():164-173. PubMed ID: 27669503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group study.
    Oude Ophuis CM; Verhoef C; Rutkowski P; Powell BW; van der Hage JA; van Leeuwen PA; Voit CA; Testori A; Robert C; Hoekstra HJ; Grünhagen DJ; Eggermont AM; van Akkooi AC
    Eur J Surg Oncol; 2016 Dec; 42(12):1906-1913. PubMed ID: 27266406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel node biopsy in patients with melanoma improves the accuracy of staging when added to clinicopathological features of the primary tumor.
    El Sharouni MA; Stodell MD; Ahmed T; Suijkerbuijk KPM; Cust AE; Witkamp AJ; Sigurdsson V; van Diest PJ; Scolyer RA; Thompson JF; van Gils CH; Lo SN
    Ann Oncol; 2021 Mar; 32(3):375-383. PubMed ID: 33253862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
    Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
    Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma.
    Wagner JD; Gordon MS; Chuang TY; Coleman JJ; Hayes JT; Jung SH; Love C
    Cancer; 2000 Jul; 89(2):453-62. PubMed ID: 10918179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognosis after sentinel node biopsy in malignant melanoma].
    Lock-Andersen J; Horn J; Sjøstrand H
    Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of ultrasound guided fine needle aspiration cytology in conjunction with sentinel node biopsy support step-wise approach in melanoma.
    Oude Ophuis CMC; Verhoef C; Grünhagen DJ; Siegel P; Schoengen A; Röwert-Huber J; Eggermont AMM; Voit CA; van Akkooi ACJ
    Eur J Surg Oncol; 2017 Aug; 43(8):1509-1516. PubMed ID: 28262276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial.
    Morton DL; Cochran AJ; Thompson JF; Elashoff R; Essner R; Glass EC; Mozzillo N; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Wang HJ;
    Ann Surg; 2005 Sep; 242(3):302-11; discussion 311-3. PubMed ID: 16135917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of lymphoscintigraphy technique on the outcome of sentinel node biopsy in 1,313 patients with cutaneous melanoma: an Italian Multicentric Study (SOLISM-IMI).
    Rossi CR; De Salvo GL; Trifirò G; Mocellin S; Landi G; Macripò G; Carcoforo P; Ricotti G; Giudice G; Picciotto F; Donner D; Di Filippo F; Montesco MC; Casara D; Schiavon M; Foletto M; Baldini F; Testori A
    J Nucl Med; 2006 Feb; 47(2):234-41. PubMed ID: 16455628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Checkpoint blockade and BRAF/MEK therapy in the therapeutic setting improved the overall survival after sentinel node biopsy: A retrospective study comparing patients with primary care between 1998-2009 and 2010-2017.
    Kretschmer L; Bernhard L; Leha A; Kromer C; Julius K; Schön MP; Schnabel V
    Int J Cancer; 2023 Jul; 153(2):380-388. PubMed ID: 36789913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel node biopsy (SNB) in malignant melanoma as same day procedure vs delayed procedure: clinical and economic outcome.
    Rødgaard JC; Kramer S; Stolle LB
    J Plast Surg Hand Surg; 2014 Aug; 48(4):265-9. PubMed ID: 24328901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel Node Biopsy for Melanoma Patients with a Local Recurrence or In-Transit Metastasis.
    Nijhuis AAG; Santos Filho IDAO; Holtkamp LHJ; Uren RF; Thompson JF; Nieweg OE
    Ann Surg Oncol; 2020 Feb; 27(2):561-568. PubMed ID: 31407174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focused Ultrasound Surveillance of Lymph Nodes Following Lymphoscintigraphy Without Sentinel Node Biopsy: A Useful and Safe Strategy in Elderly or Frail Melanoma Patients.
    Ipenburg NA; Thompson JF; Uren RF; Chung D; Nieweg OE
    Ann Surg Oncol; 2019 Sep; 26(9):2855-2863. PubMed ID: 31240588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of Melanoma Patients Who Did Not Proceed to Sentinel Node Biopsy After Preoperative Lymphoscintigraphy.
    Ipenburg NA; Nieweg OE; Uren RF; Thompson JF
    Ann Surg Oncol; 2017 Jan; 24(1):117-126. PubMed ID: 27480356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients.
    van der Ploeg AP; van Akkooi AC; Haydu LE; Scolyer RA; Murali R; Verhoef C; Thompson JF; Eggermont AM
    Eur J Cancer; 2014 Jan; 50(1):111-20. PubMed ID: 24074765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel node biopsy in melanoma: Current controversies addressed.
    Madu MF; Wouters MW; van Akkooi AC
    Eur J Surg Oncol; 2017 Mar; 43(3):517-533. PubMed ID: 27590685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome following sentinel node biopsy plus wide local excision versus wide local excision only for primary cutaneous melanoma: analysis of 5840 patients treated at a single institution.
    van der Ploeg AP; Haydu LE; Spillane AJ; Quinn MJ; Saw RP; Shannon KF; Stretch JR; Uren RF; Scolyer RA; Thompson JF
    Ann Surg; 2014 Jul; 260(1):149-57. PubMed ID: 24633018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of incomplete sentinel node biopsy procedures and sentinel node positivity rates as surgical quality-assurance parameters in melanoma patients.
    Spillane AJ; Haydu LE; Lee NC; Uren RF; Stretch JR; Shannon KF; Quinn MJ; Saw RP; McCarthy WH; Thompson JF
    Ann Surg Oncol; 2012 Nov; 19(12):3919-25. PubMed ID: 22644517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.